Clinical review evaluates FDA-approved medications for alcohol use disorder, highlighting distinct dosing, efficacy, and safety profiles to optimize treatment selection.
This JAMA Insights examines US Food and Drug Administration–approved medications for alcohol use disorder, including the dosing, efficacy, and adverse effects of naltrexone, acamprosate, and disulfiram.
No takes yet. Share an insight, caveat, or question.
Stephen R. Holt (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: